Delivery Order SPE2DB22D2206-SPE2DB25FHD62
Award Date
5/28/25
Potential Completion Date
6/18/25
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialized medication. The contract has a firm fixed price of $7,438.00 and a period of performance through May 30, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product, with a ceiling value of $5,578.50. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $9,297.50, and a performance period ending on June 3, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This...
This federal contract award, with a ceiling value of $9,297.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS, a medical product used for various treatments. The contract is a firm fixed-price delivery order, with a period of performance through May 30, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,677.52, is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication. The award was made on December 23, 2022, with a completion date of January 18, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
The Defense Logistics Agency (DLA) awarded a $8,772.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565703763 ZOLADEX 10.8 MG IMPLANT SYRNS. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a range of essential medical commodities from Amerisourcebergen to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,619.40, is for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 15, 2025. This award is not designated as a set-aside contract. The contract is associated with a...
This is a $9,297.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4567850742 ZOLADEX 10.8 MG IMPLANT SYRNS, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS. The contract has a ceiling value of $1,260.71 and a completion date of June 5, 2025. The award is not set aside and represents an open competition. Amerisourcebergen Drug Corp is a for-profit organization based in Conshohocken, Pennsylvania, and a critical supplier of medical and pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,631.84, is for the delivery of ZOLADEX 10.8 MG IMPLANT SYRNS medical devices. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for the company to provide a...